Lin Jonathan 4
4 · EQUINIX INC · Filed Mar 13, 2026
Research Summary
AI-generated summary of this filing
Equinix (EQIX) CBO Jonathan Lin Sells 635 Shares
What Happened
Jonathan Lin, Chief Business Officer of Equinix, was granted 635 fully‑vested restricted stock units (RSUs) under the 2025 Annual Incentive Plan on March 11, 2026 (footnotes F13/F14). Those units converted/ were exercised into 635 shares and the shares were sold in open‑market transactions on March 12, 2026 for aggregate proceeds of approximately $613,228. The exercise/grant entries are reported at $0 (derivative conversion/award); the cash proceeds come from the 03/12 sales.
Key Details
- Transaction dates: grant/exercise reported 2026-03-11; open‑market sales executed 2026-03-12; Form 4 filed 2026-03-13 (timely).
- Shares sold: 635 shares sold in multiple trades on 03/12 at prices shown (weighted average reporting). Total proceeds ≈ $613,228.
- Price range: reported per footnotes as roughly $957.55 to $969.80 across the multiple executions (weighted averages and sub‑ranges provided in footnotes F2–F12).
- Sales plan: these sales were made pursuant to a 10b5‑1 trading plan (footnote F1).
- Shares owned after transaction: not specified in the provided filing details.
- Notable footnotes: F13 confirms the RSU award was 100% granted after performance criteria were met; F14 notes the RSU award expires upon termination of service.
Context
This was a grant/derivative conversion followed by immediate/open‑market sales. That pattern is common for executives monetizing vested awards or covering tax obligations. The sales were executed under a pre‑arranged 10b5‑1 plan, which typically indicates trades were programmed in advance rather than ad hoc decisions. The filing appears timely (Form 4 filed within required period).
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-03-11+635→ 11,422.847 total - Sale
Common Stock
[F1][F2]2026-03-12$958.00/sh−18$17,244→ 11,404.847 total - Sale
Common Stock
[F1][F3]2026-03-12$959.00/sh−31$29,729→ 11,373.847 total - Sale
Common Stock
[F1][F4]2026-03-12$960.13/sh−22$21,123→ 11,351.847 total - Sale
Common Stock
[F1][F5]2026-03-12$961.17/sh−52$49,981→ 11,299.847 total - Sale
Common Stock
[F1][F6]2026-03-12$962.60/sh−42$40,429→ 11,257.847 total - Sale
Common Stock
[F1][F7]2026-03-12$963.72/sh−18$17,347→ 11,239.847 total - Sale
Common Stock
[F1][F8]2026-03-12$965.34/sh−37$35,718→ 11,202.847 total - Sale
Common Stock
[F1][F9]2026-03-12$966.16/sh−41$39,613→ 11,161.847 total - Sale
Common Stock
[F1][F10]2026-03-12$967.44/sh−187$180,912→ 10,974.847 total - Sale
Common Stock
[F1][F11]2026-03-12$968.30/sh−115$111,354→ 10,859.847 total - Sale
Common Stock
[F1][F12]2026-03-12$969.14/sh−72$69,778→ 10,787.847 total - Award
Restricted Stock Unit
[F13][F14]2026-03-11+635→ 635 totalExercise: $0.00→ Common Stock (635 underlying) - Exercise/Conversion
Restricted Stock Unit
[F13][F14]2026-03-11−635→ 0 totalExercise: $0.00→ Common Stock (635 underlying)
Footnotes (14)
- [F1]Shares sold pursuant to a 10b5-1 Trading Plan.
- [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $966.805 to $967.78 inclusive.
- [F11]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $967.84 to $968.77 inclusive.
- [F12]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $968.87 to $969.80 inclusive.
- [F13]Under the 2025 Annual Incentive Plan, subject to meeting performance criteria, the reporting person was eligible to receive a bonus to be paid in the form of fully-vested restricted stock units. The Compensation Committee has determined that the performance criteria were attained, and therefore 100% of the award was granted on March 11, 2026 as reported in this Form 4.
- [F14]Restricted stock unit award expires upon reporting person's termination of service.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $957.55 to $958.48, inclusive. The reporting person undertakes to provide to Equinix, Inc, any security holder of Equinix Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 12 to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $958.59 to $959.455 inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $959.625 to $960.4200 inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $960.875 to $961.59 inclusive.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $962.13 to $963.00 inclusive.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $963.395 to $964.00 inclusive.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $964.71 to $965.70 inclusive.
- [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $965.78 to $966.74 inclusive.